Multiple Myeloma and related malignancies 2nd edition

In the last 15 to 20 years significant advancements in the understanding of the pathophysiology of multiple myeloma and related malignancies have led to the adoption of new and effective therapies. Thus, the time has come for a thorough biological and clinical update. In planning this international meeting, we have indeed kept in mind this aim which will hopefully provide specialists in Hematology, Oncology and Internal Medicine as well as young researchers, residents, doctoral and undergraduate students with a unique opportunity to deepen and update their knowledge with regard to the available and emerging developments in the biology and management of multiple myeloma and related malignancies. A number of internationally recognized speakers, coming from our own and other countries, are expected to deliver state-of-the-art lectures on cutting edge topics. These will include genetic and molecular features of myeloma biology, mechanisms of disease progression, novel diagnostic approaches, new therapeutic molecules and combinations
thereof specifically targeting tumor cells and/or their microenvironment. Autologous and allogeneic stem cell transplantation will also be the object of intensive scrutiny. Finally, two ‘hot points’ sessions have been planned in order to provide basic and clinical researchers with the opportunity to present and discuss the results of their endeavours.
Based on these premises, we are confident that at the end of the meeting all of us will be enriched with fresh stimuli and renewed enthusiasm, with the deep awareness that the enduring challenges posed by multiple myeloma and cognate tumors may now be faced with more rational and more effective achievements

Franco Dammacco, Angelo Vacca

Registration form
Scientific preliminary program